ASAH1 and breast cancer: Indeed, higher expressions of ASAH1 detected in ER+ compared to ER- BCs was mainly associated with Luminal A cancers, which are known to have the better prognosis and positive outcomes of all BC subtypes, suggesting the high ASAH1 expression as a useful biomarker for the Luminal phenotype (Table 1) [71].